Career Search
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Notice to applicants for US job openings. Learn More
Showing 34 results
- Sort by Sort ascending
- Job Title
- Business Sort descending
- Location
- Site
- Date Posted
| Job Title | Business Sort descending | Location | Site | Date Posted |
|---|---|---|---|---|
| Global Program Clinical Head - Dermatology Regular, Full time | Innovative Medicines | USA +Alternative Locations | Basel (City) | May 15, 2024 |
| Clinical Development Medical Director - Rheumatology Regular, Full time | Innovative Medicines | USA +Alternative Locations | East Hanover | Sep 30, 2024 |
| Head, Clinical Development Strategy & Integration Lead Regular, Full time | Innovative Medicines | Switzerland +Alternative Locations | Basel (City) | Sep 12, 2024 |
| Director Quantitative Safety Scientist Regular, Full time | Innovative Medicines | Ireland +Alternative Locations | Dublin (Novartis Corporate Center (NOCC)) | Sep 17, 2024 |
| Senior Study Leader (Associate Director) Regular, Full time | Innovative Medicines | Ireland | Dublin (Novartis Corporate Center (NOCC)) | Aug 29, 2024 |
| Director, Capabilities & Engagement, Clinical Development Regular, Full time | Innovative Medicines | Ireland +Alternative Locations | Dublin (Novartis Corporate Center (NOCC)) | Sep 02, 2024 |
| Clinical Development Medical Director - Renal **80-100% Regular, Full time | Innovative Medicines | Switzerland +Alternative Locations | Basel (City) | Sep 20, 2024 |
| Global Program Clinical Head - CRM Regular, Full time | Innovative Medicines | Switzerland +Alternative Locations | Basel (City) | Sep 20, 2024 |
| Study Start Up Senior Lead Regular, Full time | Innovative Medicines | Ireland +Alternative Locations | Dublin (Novartis Corporate Center (NOCC)) | Sep 24, 2024 |
| Submission Readiness Document Manager Regular, Full time | Innovative Medicines | United Kingdom +Alternative Locations | London (The Westworks) | Sep 24, 2024 |